Overview
Chris Twelves practices in Leeds, United Kingdom. Twelves is rated as an Advanced expert by MediFind in the treatment of Metastatic Brain Tumor. Their top areas of expertise are Breast Cancer, Metastatic Brain Tumor, Colorectal Cancer, and Agranulocytosis.
Their clinical research consists of co-authoring 169 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Metastatic Brain Tumor.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerTwelves isDistinguished. Learn about Breast Cancer.
- Advanced
- Colorectal CancerTwelves isAdvanced. Learn about Colorectal Cancer.
- Metastatic Brain TumorTwelves isAdvanced. Learn about Metastatic Brain Tumor.
- Experienced
- AgranulocytosisTwelves isExperienced. Learn about Agranulocytosis.
- AstrocytomaTwelves isExperienced. Learn about Astrocytoma.
- Ataxia-TelangiectasiaTwelves isExperienced. Learn about Ataxia-Telangiectasia.
- Bone TumorTwelves isExperienced. Learn about Bone Tumor.
- Brain TumorTwelves isExperienced. Learn about Brain Tumor.
- COVID-19Twelves isExperienced. Learn about COVID-19.